ENG and hepatocellular carcinoma: Anti-endoglin mAb established by Tan et al. and passively transfused through tail veins into two murine hepatoma models, effectively suppressed tumour growth, inhibited angiogenesis, increased cell apoptosis within the tumour tissue, and prolonged the survival rate of these mice [136].